title: [Thyroid cancer. In search of individualized treatment].
abstract: The incidence of thyroid cancer has increased exponentially around the world (mostly papillary thyroid carcinoma). This growth may reflect the combined effects of increased screening practices, together with changes in risk factors for thyroid cancer. In spite of this, disease specific mortality remained stable in the last three decades. Due to the fact that patients with papillary thyroid carcinoma often have a very good prognosis, with high survival in the long term follow-up compared with other types of carcinomas, there has been no need to change the standard treatment. The mainstays of thyroid cancer treatment are surgery (total or near-total thyroidectomy) with or without the additional administration of radioiodine (131I). These approaches are now in the center of discussion in all global forums. The current trend is to ensure the most effective and less harmful treatment and the most important issue at this point is to individualize patients according to tumor stage and risk of recurrence, to define which patients will benefit of more aggressive therapy and who could be handled with a more conservative approach.
authors.affiliation: Sección Tiroides, División Endocrinología, Hospital de Clínicas, Universidad de Buenos Aires, Buenos Aires, Argentina. fpitoia@intramed.net
authors.forename: Fabián
authors.initials: F
authors.lastname: Pitoia
authors.forename: Andrea
authors.initials: A
authors.lastname: Cavallo
mesh_terms: D055011:Ablation Techniques; D006801:Humans; D015994:Incidence; D037981:Neck Dissection / Q000379:methods; D057285:Precision Medicine; D015995:Prevalence; D012307:Risk Factors; D013961:Thyroid Gland / Q000601:surgery*; D013964:Thyroid Neoplasms / Q000145:classification / Q000453:epidemiology / Q000601:surgery*; D057073:Thyrotropin Alfa / Q000008:administration & dosage; D016896:Treatment Outcome
chemical_list: D057073:Thyrotropin Alfa